Clinical Trial Update: EndoTic - Endothelium and Ticagrelor [NA]

View source ↗

Summary

EndoTic trial updates indicate completion of the study evaluating endothelium-related effects of ticagrelor in acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Fundación Investigación Sanitaria en León | Conditions: Acute Coronary Syndrome (ACS) | NA | Status: COMPLETED